Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 39.00 INR
Change Today +0.45 / 1.17%
Volume 44.8K
As of 6:00 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

zenotech laboratories ltd (ZTL) Snapshot

Open
40.00
Previous Close
38.55
Day High
40.45
Day Low
36.65
52 Week High
04/17/15 - 71.25
52 Week Low
11/27/14 - 22.20
Market Cap
1.3B
Average Volume 10 Days
18.6K
EPS TTM
-3.64
Shares Outstanding
34.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ZENOTECH LABORATORIES LTD (ZTL)

Related News

No related news articles were found.

zenotech laboratories ltd (ZTL) Related Businessweek News

No Related Businessweek News Found

zenotech laboratories ltd (ZTL) Details

Zenotech Laboratories Limited, a pharmaceutical specialty generic injectables company, manufactures bio-technology products. Its pharmaceutical product portfolio serves niche therapy areas, including oncology and anesthesiology. The company was formerly known as Sunline Technologies Limited and changed its name to Zenotech Laboratories Limited in August 2004. Zenotech Laboratories Limited was incorporated in 1989 and is based in Hyderabad, India.

Founded in 1989

zenotech laboratories ltd (ZTL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zenotech laboratories ltd (ZTL) Key Developments

Zenotech Laboratories Ltd Announces Board Changes

Zenotech Laboratories Ltd. announced that the Board of Directors of the company on June 30, 2015, approved the appointment of Mr. Virendra Gunvantrai Bhatt as independent director of the company. Further the company also approved that, Mr. Vijay G. Agarwal & Mr. Surinder Kumar Kohli have resigned from their offices as directors of the company with immediate effect.

Zenotech Laboratories Limited Announces Resignation of R. S. Bakshi from the Board, Effective from June 01, 2015

Zenotech Laboratories Limited announced that Dr. R. S. Bakshi, Independent Director of the company, has resigned from the Board, effective from June 01, 2015.

Zenotech Laboratories Limited Reports Unaudited Standalone Earnings Results for the Fourth Quarter and Audited Standalone Earnings Results for the Full Year Ended March 31, 2015

Zenotech Laboratories Limited reported unaudited standalone earnings results for the fourth quarter and audited standalone earnings results for the full year ended March 31, 2015. For the quarter, the company reported total income from operations (net) of INR 8.912 million compared to INR 5.319 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 86.414 million compared to INR 33.957 million a year ago. Loss from ordinary activates before tax was INR 102.037 million compared to INR 26.083 million a year ago. Net loss was INR 102.037 million or INR 2.96 per basic and diluted share before and after extraordinary items compared to INR 26.083 million or INR 0.76 per basic and diluted share before and after extraordinary items a year ago. For the full year, the company reported total income from operations (net) of INR 40.767 million compared to INR 27.557 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 241.070 million compared to INR 205.558 million a year ago. Loss from ordinary activates before tax was INR 304.143 million compared to INR 228.554 million a year ago. Net loss was INR 304.143 million or INR 8.83 per basic and diluted share before and after extraordinary items compared to INR 228.554 million or INR 6.64 per basic and diluted share before and after extraordinary items a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZTL:IN 39.00 INR +0.45

ZTL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ZTL.
View Industry Companies
 

Industry Analysis

ZTL

Industry Average

Valuation ZTL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 32.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 18.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZENOTECH LABORATORIES LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.